Measles, mumps and rubella vaccine 12 months after hematopoietic stem cell transplantation

The measles, mumps and rubella (MMR) vaccine is usually recommended from 24 months after a hematopoietic stem cell transplant (HSCT). Some authors have demonstrated that the MMR vaccination can be safe from 12 months post-HSCT in non-immunosuppressed patients, as recommended by the Brazilian Nationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Randi, Bruno Azevedo, Fernandes, Eder Gatti, Higashino, Hermes Ryoiti, Lopes, Marta Heloisa, Rocha, Vanderson Geraldo, Costa, Silvia Figueiredo, Sartori, Ana Marli Christovam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical de São Paulo 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027056/
https://www.ncbi.nlm.nih.gov/pubmed/36946817
http://dx.doi.org/10.1590/S1678-9946202365021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027056/
https://www.ncbi.nlm.nih.gov/pubmed/36946817
http://dx.doi.org/10.1590/S1678-9946202365021

Ejemplares similares